Overexpression of Uric Acid Transporter SLC2A9 Inhibits Proliferation of Hepatocellular Carcinoma Cells

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated mortality worldwide. Although the mechanisms of HCC progression are not well understood, recent studies demonstrated the potential contribution of uric acid transporter SLC2A9 to tumor suppression. However, the roles and...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiaoying, Yang, Jing, Li, Dong, Guo, Zewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848443/
https://www.ncbi.nlm.nih.gov/pubmed/29523220
http://dx.doi.org/10.3727/096504018X15199489058224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848443/
https://www.ncbi.nlm.nih.gov/pubmed/29523220
http://dx.doi.org/10.3727/096504018X15199489058224

Ejemplares similares